chronic heart failure
Effect of a 6 month pedometer based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials
10
Original Article Serum uric acid NT-ProBNP and hs-CRP as biomarkers in chronic heart failure
8
Small‐molecule‐mediated chemical knock‐down of MuRF1/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure
14
Chronic heart failure: Role of the GP in management
7
Candesartan cilexetil in the treatment of chronic heart failure
8
Chronic heart failure - health and social problem
8
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
9
Carvedilol in the treatment of elderly patients with chronic heart failure
16
CHRONIC HEART FAILURE CAUSES OSTEOPATHY OR IS OSTEOPATHY A FACTOR IN DEVELOPMENT OF CHRONIC HEART FAILURE?
5
Cytokines as new treatment targets in chronic heart failure
7
Chronic heart failure in Japan: Implications of the CHART studies
12
Anemia associated with chronic heart failure: current concepts
12
Nonalcoholic fatty liver disease and chronic kidney disease in patients with chronic heart failure
6
Pharmacotherapy of Chronic Heart Failure
22
Resistance training for patients with chronic heart failure
183
Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
7
New insight into device therapy for chronic heart failure
288
Impact of chemical elements on heart failure progression in coronary heart disease patients
8
COPD in patients with stable heart failure in the primary care setting
6
123023.pdf
38